3Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community-acquired pneumonia[J].N Engl J Med,1997,336:243-250.
4Skerrett SJ.Diagnostic testing for community-acquired pneumonia[J].Clin Chest Med,1999,20:531-548.
5Dean NC,Silver MP,Bateman KA,et al.Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia[J].Am J Med,2001,110:451-457.
6Niederman MS.Guidelines for the management of community-acquired pneumonia[J].Med Clin North Am,2001,85:1493-1501.
7Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia:diagnosis assessment of severity,antimicrobial therapy and prevention[J].Am J Respir Crit Care Med,2001,163:1730-1754.
8Ho PL,Yung RW,Tsang DN,et al.Increasing resistance of streptococcus pneumonia to fluroquinotones:results of a Hong Kong multicentre study in 2000[J].J Antimicrob Chemother,2001,48:659-665.
10Lin E,Stank R J,Mufson M A.Lack of synergy of Erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro[J].Antimicrob Agents Chemother,2003,47(3):1151
